切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2023, Vol. 09 ›› Issue (02) : 162 -167. doi: 10.3877/cma.j.issn.2096-1537.2023.02.006

临床研究

卒中开颅术后患者脓毒症发生率及其对预后的影响
周建芳, 张琳琳(), 周建新   
  1. 100070 北京,首都医科大学附属北京天坛医院重症医学科
  • 收稿日期:2022-09-04 出版日期:2023-05-28
  • 通信作者: 张琳琳
  • 基金资助:
    北京市科学技术委员会“首都临床诊疗技术研究及转化应用”项目(Z201100005520050)

Incidence of sepsis in post-craniotomy stroke patients and its impact on prognosis

Jianfang Zhou, Linlin Zhang(), Jianxin Zhou   

  1. Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  • Received:2022-09-04 Published:2023-05-28
  • Corresponding author: Linlin Zhang
引用本文:

周建芳, 张琳琳, 周建新. 卒中开颅术后患者脓毒症发生率及其对预后的影响[J/OL]. 中华重症医学电子杂志, 2023, 09(02): 162-167.

Jianfang Zhou, Linlin Zhang, Jianxin Zhou. Incidence of sepsis in post-craniotomy stroke patients and its impact on prognosis[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 162-167.

目的

探讨卒中开颅术后患者脓毒症的发病率及其对预后的影响。

方法

本研究为前瞻性、单中心、队列研究。纳入2017年1月1日至2018年12月31日入住北京天坛医院ICU的卒中开颅术后且ICU住院时间≥24 h的成年患者(排除开颅术前合并脓毒症者)。收集患者的基础资料(年龄、性别、基础疾病等),主要诊断,手术相关信息等,对于合并感染和(或)脓毒症的患者,记录感染部位及病原菌。所有患者随访至出院(存活或死亡),记录患者ICU住院时间、总住院时间、住院花费、出院时格拉斯哥预后评分(GOS)等。

结果

共纳入226例卒中患者,其中男性115例(50.9%),女性111例(49.1%);年龄为(51.6±13.6)岁;因出血性卒中入院者197例(87.2%),因缺血性卒中入院者29例(12.8%)。所有患者中,122例出现感染,76例合并脓毒症,脓毒症发病率为33.6%(95% CI:27.4%~39.8%)。与非脓毒症患者相比,脓毒症患者的ICU住院时间和总住院时间均更长[13(8,22)d vs 4(2,7)d,Z=7.994,P<0.001;27(17,38)d vs 17(10,25)d,Z=5.579,P<0.001],住院花费更高[140 406(100 406,217 111)yuan vs 87 034(60 102,119 352)yuan,Z=6.297,P<0.001]。Logistic回归分析结果显示,脓毒症是患者预后不良(GOS≤3分)的独立危险因素(OR=2.205,95% CI:1.034~4.703,P=0.041)。

结论

卒中开颅术后患者住院期间合并脓毒症的风险较高;脓毒症不是患者住院期间死亡的危险因素,但可作为预后不良的独立危险因素。

Objective

To investigate the incidence of sepsis in post-craniotomy stroke patients and its impact on prognosis of patients.

Methods

This was a single-center prospective cohort study. All of the adult post-craniotomy stroke patients admitted into the intensive care unit (ICU) ward of Beijing Tiantan Hospital during study period (from January 1, 2017 to December 31, 2018) and with an ICU length of stay (LOS) longer than 24 hours were eligible. Patients with sepsis before craniotomy were excluded. Demographic and baseline clinical characteristics (age, gender, underlying disease, etc.), information about main diagnosis and surgery were collected. All patients were screened daily for presence of infection and sepsis. For patients with infection and/or sepsis, the infection sites and pathogens were recorded. All patients were followed up until discharge (alive or dead). The ICU LOS, hospital LOS, hospitalization costs, and Glasgow outcome scale (GOS) at discharge were recorded.

Results

During study period, a total of 226 patients were included, among whom 115 (50.9%) were male and 111 (49.1%) were female. The mean age was (51.6±13.6) years. Patients with hemorrhagic stroke accounted for 87.2% (n=197), and patients with ischemic stroke accounted for 12.8% (n=29). Of all patients, 122 developed infection and 76 developed sepsis. The incidence of sepsis was 33.6% (95% CI: 27.4%-39.8%). Compared with non-septic patients, septic patients had longer median ICU LOS [13 (8, 22) d vs 4 (2, 7) d, Z=7.994, P<0.001], longer hospital LOS [27 (17, 38) d vs 17 (10, 25) d, Z=5.579, P<0.001], and higher hospitalization costs [140 406 (100 406, 217 111) yuan vs 87 034 (60 102, 119 352) yuan, Z=6.297, P<0.001]. Logistic regression analysis showed that sepsis was not associated with death in stroke patients after craniotomy, but sepsis was an independent risk factor for poor prognosis (GOS≤3 points) (OR=2.205, 95% CI: 1.034-4.703, P=0.041).

Conclusions

Patients have a higher risk of complicated sepsis during hospitalization after stroke craniotomy. Sepsis is not a risk factor for death during hospitalization, but can serve as an independent risk factor for poor prognosis.

表1 226例卒中患者人口统计学特征及预后情况
变量 所有患者(226例) 脓毒症(76例) 非脓毒症(150例) 统计值 P
年龄(岁,
x¯
±s
51.6±13.6 54.3±12.7 50.3±13.9 t=2.118 0.035
性别[例(%)] χ2=4.259 0.039
115(50.9) 46(60.5) 69(46.0)
111(49.1) 30(39.5) 81(54.0)
吸烟[例(%)] 52(23.0) 20(26.3) 32(21.3) χ2=0.707 0.400
饮酒[例(%)] 39(17.3) 12(15.8) 27(18.0) χ2=0.173 0.678
入院类别[例(%)] χ2=0.005 1.000
择期手术 142(62.8) 48(63.2) 94(62.7)
急诊手术 84(37.2) 28(36.8) 56(37.3)
既往病史[例(%)]
高血压 111(49.1) 42(55.3) 69(46.0) χ2=1.732 0.188
糖尿病 27(11.9) 10(13.2) 17(11.3) χ2=0.160 0.689
脑血管病 41(18.1) 13(17.1) 28(18.7) χ2=0.083 0.774
实体肿瘤 6(2.7) 3(3.9) 3(2.0) χ2=0.740 0.407
冠心病 12(5.3) 4(5.3) 8(5.3) χ2=0.039 1.000
Charlson合并症指数[MQ25Q75)] 0(0,1) 0(0,1) 0(0,1) Z=0.349 0.727
NIHSS评分[分,MQ25Q75)] 17(6,25) 14(6,24) 20(7,29) Z=1.368 0.171
APACHE Ⅱ评分(分,
x¯
±s
17.0±6.1 19.2±5.5 15.8±6.1 t=4.056 <0.001
ICU第1天SOFA评分[分,MQ25Q75)] 5(3,6) 6(5,7) 4(2,6) Z=4.967 <0.001
术后第1天GCS评分[分,MQ25Q75)] 8(5,10) 7(5,9) 8(6,11) Z=3.424 0.001
死亡[例(%)] 31(13.7) 9(11.8) 22(14.7) χ2=0.340 0.560
ICU住院时间[d,MQ25Q75)] 6(3,12) 13(8,22) 4(2,7) Z=7.994 <0.001
总住院时间[d,MQ25Q75)] 20(13,29) 27(17,38) 17(10,25) Z=5.579 <0.001
住院花费[元,MQ25Q75)] 101 865(69 377,150 800) 140 406(100 406,217 111) 87 034(60 102,119 352) Z=6.297 <0.001
出院GOS评分[分,MQ25Q75)] 3(3.0,4.0) 3(3.0,3.8) 4(3.0,4.2) Z=3.037 <0.001
表2 226例患者卒中类型及病因统计[例(%)]
表3 脓毒症对卒中开颅术后患者预后的影响
1
Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: a report from the American Heart Association [J]. Circulation, 2022, 145(8): e153-e639.
2
Wafa HA, Wolfe CDA, Emmett E, et al. Burden of stroke in Europe: Thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years [J]. Stroke, 2020, 51(8): 2418-2427.
3
King D, Wittenberg R, Patel A, et al. The future incidence, prevalence and costs of stroke in the UK [J]. Age Ageing, 2020, 49(2): 277-282.
4
Shi K, Wood K, Shi FD, et al. Stroke-induced immunosuppression and poststroke infection [J]. Stroke Vasc Neurol, 2018, 3(1): 34-41.
5
Westendorp WF, Nederkoorn PJ, Vermeij JD, et al. Post-stroke infection: a systematic review and meta-analysis [J]. BMC Neurol, 2011, 11: 110.
6
Rangel-Frausto MS, Pittet D, Costigan M, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study [J]. JAMA, 1995, 273(2): 117-123.
7
Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012 [J]. JAMA, 2014, 311(13): 1308-1316.
8
Prescott HC, Langa KM, Liu V, et al. Increased 1-year healthcare use in survivors of severe sepsis [J]. Am J Respir Crit Care Med, 2014, 190(1): 62-69.
9
Yende S, Austin S, Rhodes A, et al. Long-term quality of life among survivors of severe sepsis: analyses of two international trials [J]. Crit Care Med, 2016, 44(8): 1461-1467.
10
Iwashyna TJ, Ely EW, Smith DM, et al. Long-term cognitive impairment and functional disability among survivors of severe sepsis [J]. Jama, 2010, 304(16): 1787-1794.
11
Berger B, Gumbinger C, Steiner T, et al. Epidemiologic features, risk factors, and outcome of sepsis in stroke patients treated on a neurologic intensive care unit [J]. J Crit Care, 2014, 29(2): 241-248.
12
Zaid Y, Rajeh A, Hosseini Teshnizi S, et al. Epidemiologic features and risk factors of sepsis in ischemic stroke patients admitted to intensive care: a prospective cohort study [J]. J Clin Neurosci, 2019, 69: 245-249.
13
Zhou J, Luo XY, Chen GQ, et al. Incidence, risk factors and outcomes of sepsis in critically ill post-craniotomy patients: a single-center prospective cohort study [J]. Front Public Health, 2022, 10: 895991.
14
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 775-787.
15
Pertsch NJ, Tang OY, Seicean A, et al. Sepsis after elective neurosurgery: incidence, outcomes, and predictive factors [J]. J Clin Neurosci, 2020, 78: 53-59.
16
Zhou J, Tian H, Du X, et al. Population-based epidemiology of sepsis in a subdistrict of Beijing [J]. Crit Care Med, 2017, 45(7): 1168-1176.
17
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study [J]. Crit Care Med, 2006, 34(2): 344-353.
18
Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study [J]. Lancet, 2020, 395(10219): 200-211.
19
Kuramatsu JB, Biffi A, Gerner ST, et al. Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar intracerebral hemorrhage [J]. Jama, 2019, 322(14): 1392-1403.
20
Oh SE, Parikh NS. Recent advances in the impact of infection and inflammation on stroke risk and outcomes [J]. Curr Neurol Neurosci Rep, 2022, 22(3): 161-170.
21
Iadecola C, Buckwalter MS, Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential [J]. J Clin Invest, 2020, 130(6): 2777-2788.
22
Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine [J]. Stroke, 2003, 34(4): 975-981.
23
Sellars C, Bowie L, Bagg J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study [J]. Stroke, 2007, 38(8): 2284-2291.
24
Klompas M, Branson R, Eichenwald EC, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update [J]. Infect Control Hosp Epidemiol, 2014, 35(8): 915-936.
25
Korinek AM. Risk factors for neurosurgical site infections after craniotomy: a prospective multicenter study of 2944 patients. The French Study Group of Neurosurgical Infections, the SEHP, and the C-CLIN Paris-Nord. Service Epidemiologie Hygiene et Prevention [J]. Neurosurgery, 1997, 41(5): 1073-1079; discussion 1079-1081.
26
Kourbeti IS, Vakis AF, Ziakas P, et al. Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis [J]. J Neurosurg, 2015, 122(5): 1113-1119.
27
Rubeli SL, D'Alonzo D, Mueller B, et al. Implementation of an infection prevention bundle is associated with reduced surgical site infections in cranial neurosurgery [J]. Neurosurg Focus, 2019, 47(2): E3.
28
Ehler J, Petzold A, Sharshar T, et al. Biomarker panel to differentiate brain injury from brain dysfunction in patients with sepsis-associated encephalopathy [J]. Crit Care Med, 2020, 48(5): e436-e437.
[1] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[2] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[3] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[4] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[7] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[8] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[9] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[10] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[11] 林科灿, 罗柳平. 肝胰十二指肠切除术在胆囊癌和胆管癌应用中的关键问题[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 774-778.
[12] 刘郁, 段绍斌, 丁志翔, 史志涛. miR-34a-5p 在结肠癌患者的表达及其与临床特征及预后的相关性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 485-490.
[13] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 耿晓坤. 缺血性卒中后无效再灌注的时间窗、组织窗与神经保护[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(06): 636-636.
阅读次数
全文


摘要